logo BDSP

Base documentaire

  1. The international consensus process on psychopharmacology and intellectual disability.

    Article - En anglais

    The present authors invited 115 scientists, practitioners and consumers from 11 nations to form an international consensus panel on best practices and clinical effects regarding psychoactive medicines and intellectual disability.

    Co-sponsors included the American Association on Mental Retardation, the American Psychiatric Association, the American Psychological Association, the National Institute of Mental Health, the National Association on Dual Diagnosis and The Arc of the United States.

    The panel developed 21 reports that were revised to reflect comments from 351 participants at a 1995 Ohio State University conference in Columbus, OH, USA.

    The reports will be published as chapters in a forthcoming book entitled Psychotropic Medication and Developmental Disabilities : The International Consensus Handbook.

    The need for research and training programmes is discussed.

    Mots-clés Pascal : Arriération mentale, Traitement, Chimiothérapie, Psychotrope, Trouble psychiatrique, Prévalence, Epidémiologie, Toxicité, Formation professionnelle, Personnel sanitaire, Législation, Etats Unis, Amérique du Nord, Amérique, Pratique professionnelle, Homme, Déficience intellectuelle, Trouble développement

    Mots-clés Pascal anglais : Mental retardation, Treatment, Chemotherapy, Psychotropic, Mental disorder, Prevalence, Epidemiology, Toxicity, Occupational training, Health staff, Legislation, United States, North America, America, Professional practice, Human, Intellectual deficiency, Developmental disorder

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0090359

    Code Inist : 002B02B11. Création : 14/05/1998.